- Correction
- Open access
- Published:
Correction to: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
Molecular Cancer volume 19, Article number: 89 (2020)
Correction to: Mol Cancer (2019) 18:43
a. Migration and invasion ability of parental and resistant CRC cells were assessed by Transwell assay (replace Fig. 1e). b. The immunofluorescence analysis of nuclear foci for γ-H2AX expression induced by oxaliplatin in parental and resistant cells after 24 h oxaliplatin exposure. Scale bars, 10 μm (replace Fig. 1j). c. Migration and invasion ability of HCT116OxR cells transfected with Lv-128 and Ctrl were assessed by Transwell assay (replace Fig. 2f). d. Migration and invasion ability of HCT116OxR cells after incubated with indicated factors for 48 h were assessed by Transwell assays (replace Fig. 5d). e. Migration and invasion ability of Lv-128 transfected HCT116OxR cells in different conditions were assessed by Transwell assays (replace Fig. 6g). f. Migration and invasion ability of HT29OxR cells after incubated with indicated factors for 48 h were assessed by Transwell assays (replace Fig. S4D)
https://doi.org/10.1186/s12943-019-0981-7
Following the publication of the original article [1], the authors noticed some incorrect information are shown. Inverted-microscope pictures of transwell assay were placed in the mistaken figure inadvertently and the fluorescence-microscope picture was mistakenly switched. The correct version of figure is given in Fig. 1. The authors apologize for any inconvenience caused, and these corrections do not affect the findings or conclusions of this research.
Reference
Liu T, Zhang X, Du L, Wang Y, Liu X, Tian H, Wang L, Li P, Zhao Y, Duan W, et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer. 2019;18:43. https://doi.org/10.1186/s12943-019-0981-7.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1186/s12943-022-01627-4
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, T., Zhang, X., Du, L. et al. Correction to: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer 19, 89 (2020). https://doi.org/10.1186/s12943-020-01211-8
Published:
DOI: https://doi.org/10.1186/s12943-020-01211-8